本页面由Tiger Trade Technology Pte. Ltd.提供服务

Syndax Pharmaceuticals, Inc.

20.12
+0.14000.70%
成交量:45.61万
成交额:923.29万
市值:17.75亿
市盈率:-7.21
高:20.55
开:19.96
低:19.85
收:19.98
52周最高:25.59
52周最低:8.59
股本:8,820.06万
流通股本:7,469.08万
量比:0.43
换手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-2.7913
每股收益(LYR):-3.2949
净资产收益率:-189.53%
总资产收益率:-25.12%
市净率:42.64
市盈率(LYR):-6.11

数据加载中...

2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/19

重要事件披露

Form 8-K - Current report